All In MedTech

FDA Clearance Tracker · P240011-S011

Altaviva™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 26, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P240011-S011
Device name
Altaviva™
Applicant location
Minneapolis, MN
Received
Feb 24, 2026
Decided
Mar 26, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P240011

Device type

Device class
Class III

Every decision under product code QPT

FDA's approval statement

As written in FDA's record.

approval for several administrative changes to the protocol and for Medtronic Neuromodulation to provide the commercial Altaviva™ system at no cost to study sites

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.